Singlera Genomics

Singlera Genomics is a privately held company based in San Diego, California, with a team of 7 employees. The company is dedicated to the development of innovative diagnostic solutions in the field of liquid biopsy analysis. Singlera offers reagents and software for analyzing methylation haplotypes across a vast number of genomic locations within cell-free DNA. Their flagship product, the PanSeer assay, is a targeted methylation assay designed to detect cancer years before conventional methods, utilizing sophisticated technology paired with efficient bioinformatics analysis. Singlera also provides the ColonES assay, demonstrating exceptional sensitivity in detecting colorectal cancer and advanced adenomas while maintaining very high specificity for healthy individuals. One of Singlera Genomics' key differentiators is their focus on early cancer detection. Their PanSeer assay has the potential to revolutionize cancer diagnosis by identifying the disease years before symptoms manifest, allowing for earlier intervention and potentially improving patient outcomes. Singlera Genomics is actively seeking collaborations to bring their groundbreaking technology to market. Potential partners interested in exploring collaborations can reach out through their website, singleragenomics.com.